Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristen R Spencer

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cancer Treatment and Research|November 26, 2015
Mucosal Melanoma: Epidemiology, Biology and TreatmentKristen R Spencer, Janice M Mehnert
Rare Cancers and Therapy|May 17, 2016
When Benign Tumors Mimic Malignancies: A Case of Lymphangiomatosis Masquerading as Metastatic DiseaseKristen R Spencer, Markku M Miettinen, Robert G Maki, et al.
Journal of Investigative Medicine High Impact Case Reports|December 21, 2022
Disease Control Achieved Using Atezolizumab + Bevacizumab in a Patient With Sarcomatoid Hepatocellular Carcinoma (SHCC), a Rare Variant Excluded From the IMbrave150 TrialMaria G Fencer, Catherine H Davis, Jieqi Liu, et al.
Immunotherapy|July 21, 2021
Delayed cytokine release syndrome after neoadjuvant nivolumab: a case report and literature reviewAaron T Ciner, Howard S Hochster, David A August, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Biomarkers for Immunotherapy: Current Developments and ChallengesKristen R Spencer, Jianfeng Wang, Ann W Silk, et al.
Annals of Pancreatic Cancer|January 29, 2019
Adjuvant therapeutic strategies for resectable pancreatic adenocarcinomaNikhil Yegya-Raman, Mihir M Shah, Miral S Grandhi, et al.
Oncotarget|April 10, 2023
A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850Kristen R Spencer, Daniella E Portal, Joseph Aisner, et al.
Current Oncology (Toronto, Ont.)|July 28, 2023
Combination of Immunotherapy and Radiation Therapy in Gastrointestinal Cancers: An Appraisal of the Current Literature and Ongoing ResearchRitesh Kumar, Jongmyung Kim, Matthew P Deek, et al.
Journal of Gastrointestinal Oncology|January 24, 2022
Outcomes of patients with borderline resectable and resectable pancreatic adenocarcinoma treated with neoadjuvant three-week course chemoradiotherapy using capecitabine-based versus gemcitabine-based concurrent chemotherapyShane S Neibart, Swati Mamidanna, Anupama Chundury, et al.
Frontiers in Oncology|July 6, 2019
Rethinking the Role of Radiation Therapy in the Treatment of Unresectable Hepatocellular Carcinoma: A Data Driven Treatment Algorithm for Optimizing OutcomesMutlay Sayan, Nikhil Yegya-Raman, Stephanie H Greco, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cancer Treatment and Research|November 26, 2015
Mucosal Melanoma: Epidemiology, Biology and TreatmentKristen R Spencer, Janice M Mehnert
Rare Cancers and Therapy|May 17, 2016
When Benign Tumors Mimic Malignancies: A Case of Lymphangiomatosis Masquerading as Metastatic DiseaseKristen R Spencer, Markku M Miettinen, Robert G Maki, et al.
Journal of Investigative Medicine High Impact Case Reports|December 21, 2022
Disease Control Achieved Using Atezolizumab + Bevacizumab in a Patient With Sarcomatoid Hepatocellular Carcinoma (SHCC), a Rare Variant Excluded From the IMbrave150 TrialMaria G Fencer, Catherine H Davis, Jieqi Liu, et al.
Immunotherapy|July 21, 2021
Delayed cytokine release syndrome after neoadjuvant nivolumab: a case report and literature reviewAaron T Ciner, Howard S Hochster, David A August, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Biomarkers for Immunotherapy: Current Developments and ChallengesKristen R Spencer, Jianfeng Wang, Ann W Silk, et al.
Annals of Pancreatic Cancer|January 29, 2019
Adjuvant therapeutic strategies for resectable pancreatic adenocarcinomaNikhil Yegya-Raman, Mihir M Shah, Miral S Grandhi, et al.
Oncotarget|April 10, 2023
A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850Kristen R Spencer, Daniella E Portal, Joseph Aisner, et al.
Current Oncology (Toronto, Ont.)|July 28, 2023
Combination of Immunotherapy and Radiation Therapy in Gastrointestinal Cancers: An Appraisal of the Current Literature and Ongoing ResearchRitesh Kumar, Jongmyung Kim, Matthew P Deek, et al.
Journal of Gastrointestinal Oncology|January 24, 2022
Outcomes of patients with borderline resectable and resectable pancreatic adenocarcinoma treated with neoadjuvant three-week course chemoradiotherapy using capecitabine-based versus gemcitabine-based concurrent chemotherapyShane S Neibart, Swati Mamidanna, Anupama Chundury, et al.
Frontiers in Oncology|July 6, 2019
Rethinking the Role of Radiation Therapy in the Treatment of Unresectable Hepatocellular Carcinoma: A Data Driven Treatment Algorithm for Optimizing OutcomesMutlay Sayan, Nikhil Yegya-Raman, Stephanie H Greco, et al.
Pageof 2